Cargando…
Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda
BACKGROUND: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda. METHODS: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083017/ https://www.ncbi.nlm.nih.gov/pubmed/37041756 http://dx.doi.org/10.2147/AHMT.S397734 |
_version_ | 1785021421105184768 |
---|---|
author | Odongo Ojok, Isaac Ogwal, John Baptist Wwesige, Brian Bongomin, Felix Akello, Franceska |
author_facet | Odongo Ojok, Isaac Ogwal, John Baptist Wwesige, Brian Bongomin, Felix Akello, Franceska |
author_sort | Odongo Ojok, Isaac |
collection | PubMed |
description | BACKGROUND: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda. METHODS: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13 years residing in Pece-Laroo Division, Gulu City, Uganda. HPV vaccine coverage was defined as receipt of at least a dose of the HPV vaccine. RESULTS: A total of 197 girls, with a mean age of 11±1.4 years, were enrolled. Most participants were of the Acholi tribe (89.3%, n=176), catholic (58.4%, n=115), and in primary 5 level of education (36%, n=71). Overall, 68(35%) participants had received the HPV vaccine. Factors associated with HPV vaccine utilization were, good knowledge of the HPV vaccine (adjusted odds ratio (aOR) =0.233, 95% confidence interval (95CI): 0.037–0.640, p=0.101), methods of HPV prevention (OR=0.320, 95CI: 0.112–0.914, p = 0.033), good knowledge of the importance of HPV vaccination (OR=0.458, 95% CI: 0.334–0.960, p=0.021), knowledge on frequency of HPV vaccination (OR=0.423, 95CI:0.173–0.733, p=0.059), and good mobilization (OR=0.443, 95% CI: 0.023–0.923, p=0.012). CONCLUSION: In this community-based study, only one third of eligible girls received the HPV vaccine. Public health interventions are recommended exponentially to enhance the utilization of the HPV vaccine in this community. |
format | Online Article Text |
id | pubmed-10083017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-100830172023-04-10 Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda Odongo Ojok, Isaac Ogwal, John Baptist Wwesige, Brian Bongomin, Felix Akello, Franceska Adolesc Health Med Ther Original Research BACKGROUND: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda. METHODS: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13 years residing in Pece-Laroo Division, Gulu City, Uganda. HPV vaccine coverage was defined as receipt of at least a dose of the HPV vaccine. RESULTS: A total of 197 girls, with a mean age of 11±1.4 years, were enrolled. Most participants were of the Acholi tribe (89.3%, n=176), catholic (58.4%, n=115), and in primary 5 level of education (36%, n=71). Overall, 68(35%) participants had received the HPV vaccine. Factors associated with HPV vaccine utilization were, good knowledge of the HPV vaccine (adjusted odds ratio (aOR) =0.233, 95% confidence interval (95CI): 0.037–0.640, p=0.101), methods of HPV prevention (OR=0.320, 95CI: 0.112–0.914, p = 0.033), good knowledge of the importance of HPV vaccination (OR=0.458, 95% CI: 0.334–0.960, p=0.021), knowledge on frequency of HPV vaccination (OR=0.423, 95CI:0.173–0.733, p=0.059), and good mobilization (OR=0.443, 95% CI: 0.023–0.923, p=0.012). CONCLUSION: In this community-based study, only one third of eligible girls received the HPV vaccine. Public health interventions are recommended exponentially to enhance the utilization of the HPV vaccine in this community. Dove 2023-04-05 /pmc/articles/PMC10083017/ /pubmed/37041756 http://dx.doi.org/10.2147/AHMT.S397734 Text en © 2023 Odongo Ojok et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Odongo Ojok, Isaac Ogwal, John Baptist Wwesige, Brian Bongomin, Felix Akello, Franceska Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda |
title | Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda |
title_full | Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda |
title_fullStr | Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda |
title_full_unstemmed | Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda |
title_short | Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda |
title_sort | factors associated with the human papillomavirus vaccine coverage in gulu district, uganda |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083017/ https://www.ncbi.nlm.nih.gov/pubmed/37041756 http://dx.doi.org/10.2147/AHMT.S397734 |
work_keys_str_mv | AT odongoojokisaac factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda AT ogwaljohnbaptist factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda AT wwesigebrian factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda AT bongominfelix factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda AT akellofranceska factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda |